Sökning: (WFRF:(Veglia F.)) > Subclinical atheros...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08462naa a2201429 4500 | |
001 | oai:gup.ub.gu.se/282972 | |
003 | SwePub | |
008 | 240910s2019 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:141456399 | |
009 | oai:lup.lub.lu.se:95c10b9c-1e9f-44a3-bc04-d77fe96b5c78 | |
024 | 7 | a https://gup.ub.gu.se/publication/2829722 URI |
024 | 7 | a https://doi.org/10.1111/joim.129512 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1414563992 URI |
024 | 7 | a https://lup.lub.lu.se/record/95c10b9c-1e9f-44a3-bc04-d77fe96b5c782 URI |
040 | a (SwePub)gud (SwePub)kid (SwePub)lu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Saliba-Gustafsson, P.u Karolinska Institute,Karolinska Institutet,Stanford University,Karolinska University Hospital4 aut |
245 | 1 0 | a Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy |
264 | c 2019-07-29 | |
264 | 1 | b Wiley,c 2019 |
520 | a Background Hyperlipidaemia is a major risk factor for cardiovascular disease, and atherosclerosis is the underlying cause of both myocardial infarction and stroke. We have previously shown that the Pro251 variant of perilipin-2 reduces plasma triglycerides and may therefore be beneficial to reduce atherosclerosis development. Objective We sought to delineate putative beneficial effects of the Pro251 variant of perlipin-2 on subclinical atherosclerosis and the mechanism by which it acts. Methods A pan-European cohort of high-risk individuals where carotid intima-media thickness has been assessed was adopted. Human primary monocyte-derived macrophages were prepared from whole blood from individuals recruited by perilipin-2 genotype or from buffy coats from the Karolinska University hospital blood central. Results The Pro251 variant of perilipin-2 is associated with decreased intima-media thickness at baseline and over 30 months of follow-up. Using human primary monocyte-derived macrophages from carriers of the beneficial Pro251 variant, we show that this variant increases autophagy activity, cholesterol efflux and a controlled inflammatory response. Through extensive mechanistic studies, we demonstrate that increase in autophagy activity is accompanied with an increase in liver-X-receptor (LXR) activity and that LXR and autophagy reciprocally activate each other in a feed-forward loop, regulated by CYP27A1 and 27OH-cholesterol. Conclusions For the first time, we show that perilipin-2 affects susceptibility to human atherosclerosis through activation of autophagy and stimulation of cholesterol efflux. We demonstrate that perilipin-2 modulates levels of the LXR ligand 27OH-cholesterol and initiates a feed-forward loop where LXR and autophagy reciprocally activate each other; the mechanism by which perilipin-2 exerts its beneficial effects on subclinical atherosclerosis. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a 27OH-cholesterol | |
653 | a atherosclerosis | |
653 | a autophagy | |
653 | a liver-X-receptor | |
653 | a PLIN2 | |
653 | a reverse cholesterol transport | |
653 | a macrophage foam cells | |
653 | a accumulation | |
653 | a efflux | |
653 | a identification | |
653 | a stimulation | |
653 | a metabolism | |
653 | a receptors | |
653 | a ser251pro | |
653 | a protects | |
653 | a General & Internal Medicine | |
700 | 1 | a Pedrelli, M.u Karolinska Institute,Karolinska Institutet4 aut |
700 | 1 | a Gertow, K.u Karolinska Institute,Karolinska University Hospital4 aut |
700 | 1 | a Werngren, O.u Karolinska Institute,Karolinska University Hospital4 aut |
700 | 1 | a Janas, V.u Karolinska Institute,Karolinska University Hospital4 aut |
700 | 1 | a Pourteymour, S.4 aut |
700 | 1 | a Baldassarre, D.u University of Milan,Centro Cardiologico Monzino4 aut |
700 | 1 | a Tremoli, E.u Centro Cardiologico Monzino,University of Milan4 aut |
700 | 1 | a Veglia, F.u Centro Cardiologico Monzino4 aut |
700 | 1 | a Rauramaa, R.u University of Eastern Finland4 aut |
700 | 1 | a Smit, A. J.u University Medical Center Groningen4 aut |
700 | 1 | a Giral, P.u Pitié-Salpêtrière University Hospital4 aut |
700 | 1 | a Kurl, S.u University of Eastern Finland4 aut |
700 | 1 | a Pirro, M.u University of Perugia4 aut |
700 | 1 | a de Faire, U.u Karolinska Institute,Karolinska Institutet4 aut |
700 | 1 | a Humphries, S. E.u Karolinska Institute,Karolinska Institutet,University College London,Karolinska University Hospital4 aut |
700 | 1 | a Hamsten, A.u Karolinska Institute,Karolinska Institutet,Karolinska University Hospital4 aut |
700 | 1 | a Gonçalves, I.u Lund University,Lunds universitet,Kardiovaskulär forskning - translationella studier,Forskargrupper vid Lunds universitet,Cardiovascular Research - Translational Studies,Lund University Research Groups4 aut0 (Swepub:lu)medf-igo |
700 | 1 | a Orho-Melander, M.u Lund University,Lunds universitet,Diabetes - kardiovaskulär sjukdom,Forskargrupper vid Lunds universitet,Diabetes - Cardiovascular Disease,Lund University Research Groups4 aut0 (Swepub:lu)endo-mor |
700 | 1 | a Franco-Cereceda, A.u Karolinska Institute,Karolinska Institutet,Karolinska University Hospital4 aut |
700 | 1 | a Borén, Jan,d 1963u University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory,Sahlgrenska University Hospital4 aut0 (Swepub:gu)xborej |
700 | 1 | a Eriksson, P.u Karolinska Institute,Karolinska Institutet,Karolinska University Hospital4 aut |
700 | 1 | a Magne, J.u Karolinska Institute,Karolinska Institutet,St Jude Children´s Research Hospital, Memphis,Karolinska University Hospital4 aut |
700 | 1 | a Parini, P.4 aut |
700 | 1 | a Ehrenborg, E.4 aut |
700 | 1 | a Sirtori, C. R.4 aut |
700 | 1 | a Castelnuovo, S.4 aut |
700 | 1 | a Amato, M.4 aut |
700 | 1 | a Frigerio, B.4 aut |
700 | 1 | a Ravani, A.4 aut |
700 | 1 | a Sansaro, D.4 aut |
700 | 1 | a Tedesco, C.4 aut |
700 | 1 | a Bovis, F.4 aut |
700 | 1 | a Discacciati, A.4 aut |
700 | 1 | a Ahl, M.4 aut |
700 | 1 | a Blomgren, G.4 aut |
700 | 1 | a Eriksson, M. J.4 aut |
700 | 1 | a Fahlstadius, P.4 aut |
700 | 1 | a Heinonen, M.4 aut |
700 | 1 | a Nilson, L.4 aut |
700 | 1 | a Cooper, J.4 aut |
700 | 1 | a Acharya, J.4 aut |
700 | 1 | a Huttunen, K.4 aut |
700 | 1 | a Rauramaa, E.4 aut |
700 | 1 | a Pekkarinen, H.4 aut |
700 | 1 | a Penttila, I. M.4 aut |
700 | 1 | a Torronen, J.4 aut |
700 | 1 | a van Gessel, A. I.4 aut |
700 | 1 | a van Roon, A. M.4 aut |
700 | 1 | a Teune, G. C.4 aut |
700 | 1 | a Kuipers, W. D.4 aut |
700 | 1 | a Bruin, M.4 aut |
700 | 1 | a Nicolai, A.4 aut |
700 | 1 | a Haarsma-Jorritsma, P.4 aut |
700 | 1 | a Mulder, D. J.4 aut |
700 | 1 | a Bilo, H. J. G.4 aut |
700 | 1 | a Smeets, G. H.4 aut |
700 | 1 | a Beaudeux, J. L.4 aut |
700 | 1 | a Kahn, J. F.4 aut |
700 | 1 | a Carreau, V.4 aut |
700 | 1 | a Kontush, A.4 aut |
700 | 1 | a Karppi, J.4 aut |
700 | 1 | a Nurmi, T.4 aut |
700 | 1 | a Nyyssonen, K.4 aut |
700 | 1 | a Salonen, R.4 aut |
700 | 1 | a Tuomainen, T. P.4 aut |
700 | 1 | a Tuomainen, J.4 aut |
700 | 1 | a Kauhanen, J.4 aut |
700 | 1 | a Vaudo, G.4 aut |
700 | 1 | a Alaeddin, A.4 aut |
700 | 1 | a Siepi, D.4 aut |
700 | 1 | a Lupattelli, G.4 aut |
700 | 1 | a Schillaci, G.4 aut |
710 | 2 | a Karolinska Instituteb Karolinska Institutet4 org |
773 | 0 | t Journal of Internal Medicined : Wileyg 286:6, s. 660-675q 286:6<660-675x 0954-6820x 1365-2796 |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/joim.12951 |
856 | 4 | u http://dx.doi.org/10.1111/joim.12951x freey FULLTEXT |
856 | 4 8 | u https://gup.ub.gu.se/publication/282972 |
856 | 4 8 | u https://doi.org/10.1111/joim.12951 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:141456399 |
856 | 4 8 | u https://lup.lub.lu.se/record/95c10b9c-1e9f-44a3-bc04-d77fe96b5c78 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy